Induced pluripotency with endogenous and inducible genes

Experimental Cell Research

Volumn 314, Issue 17, 2008, Pages 3255-3263

  Duinsbergen, Dirk ^a   Eriksson, Malin ^b   't Hoen, Peter A C ^a   Frisén, Jonas ^b   Mikkers, Harald ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

iPS; Neural stem cells; Nuclear reprogramming; Pluripotency

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOXB1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE FUNCTION; GERM LAYER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TRANSGENE;

IPS;

EID: 53049097998     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.06.024     Document Type: Article

References (23)

1. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
2. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
3. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., and Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
4. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., and Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 (2008) 141-146
5. Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R., Clark A.T., and Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 2883-2888
6. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin II, and Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
7. Mikkers H., and Berns A. Retroviral insertional mutagenesis: tagging cancer pathways. Adv. Cancer Res. 88 (2003) 53-99
8. Buchholz C.J., and Cichutek K. Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold. J. Gene Med. 8 (2006) 1274-1276
9. Conti L., Pollard S.M., Gorba T., Reitano E., Toselli M., Biella G., Sun Y., Sanzone S., Ying Q.L., Cattaneo E., and Smith A. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS. Biol. 3 (2005) e283
10. Lin S.M., Du P., Huber W., and Kibbe W.A. Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res. 36 (2008) e11
11. Laird P.W., Zijderveld A., Linders K., Rudnicki M.A., Jaenisch R., and Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19 (1991) 4293
12. Chen Y.T., and Bradley A. A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells. Genesis 28 (2000) 31-35
13. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
14. Blelloch R., Venere M., Yen J., and Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 1 (2007) 245-247
15. Meissner A., Wernig M., and Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25 (2007) 1177-1181
16. Silva J., Chambers I., Pollard S., and Smith A. Nanog promotes transfer of pluripotency after cell fusion. Nature 441 (2006) 997-1001
17. T. Aoi, k. Yae, M. Nakagawa, T. Ichisaka, K. Okita, K. Takahashi, T. Chiba, S. Yamanaka. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science (2008 Feb 14) (DOI: 10.1126/science.1154884).
18. Hanna J., Markoulaki S., Schorderet P., Carey B.W., Beard C., Wernig M., Creyghton M.P., Steine E.J., Cassady J.P., Foreman R., Lengner C.J., Dausman J.A., and Jaenisch R. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133 (2008) 250-264
19. Brambrink T., Foreman R., Welstead G.G., Lengner C.J., Wernig M., Suh H., and Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2 (2008) 151-159
20. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., and Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26 (2008) 101-106
21. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., and Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23 (1995) 1686-1690
22. Pelengaris S., Littlewood T., Khan M., Elia G., and Evan G. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3 (1999) 565-577
23. Shi Y., Do J.T., Desponts C., Hahm H.S., Scholer H.R., and Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2 (2008) 525-528